FBN1 and Marfan syndrome: Corrected the pathogenic mutation FBN1 (T7498C) of Marfan syndrome in HEK293T cells and in heterozygous human embryos using the BE system, showing an overall correction rate of 89% and no detection of off-target, insertions/deletions (indels) in intended sites.